openPR Logo
Press release

Investigation announced for Investors in Xiao-I Corporation (NASDAQ: AIXI) over possible Violations of Securities Laws

An investigation for investors in Xiao-I Corporation (NASDAQ: AIXI) shares over potential securities laws violations.

An investigation for investors in Xiao-I Corporation (NASDAQ: AIXI) shares over potential securities laws violations.

An investigation was announced over potential securities laws violations by Xiao-I Corporation in connection with certain financial statements.

Investors who purchased shares of Xiao-I Corporation (NASDAQ: AIXI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Xiao-I Corporation (NASDAQ: AIXI) concerning whether a series of statements by Xiao-I Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

China based Xiao-I Corporation, through its subsidiary, Shanghai Xiao-i Robot Technology Co., Ltd., provides software services in the People's Republic of China. Xiao-I Corporation reported that its annual Total Revenue rose from $48.18 million in 2022 to $59.16 million in 2023, and that its Net Loss increased from $5.89 million in 2022 to $26.46 million in 2023.

On August 10, 2023, Xiao-I Corporation filed with the U.S. Securities and Exchange Commission its amended annual report on Form 10-K/A for the year ended December 31, 2022. In the amended annual report, Xiao-I disclosed that "should there be any changes to PRC laws and regulations or internal control policies of Bank of Ningbo in the future, [Zhizhen Artificial Technology (Shanghai) Company Limited, a Company subsidiary] then may be restricted from transferring funds from overseas to its capital account with Bank of Ningbo as a result."

Shares of Xiao-I Corporation (NASDAQ: AIXI) declined from $6.62 per share on June 02, 2023, to as low as $0.988 per share on May 15, 2024.

Those who purchased shares of Xiao-I Corporation (NASDAQ: AIXI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Xiao-I Corporation (NASDAQ: AIXI) over possible Violations of Securities Laws here

News-ID: 3506945 • Views:

More Releases from Shareholders Foundation, Inc.

Investigation announced for Investors in NASDAQ: AAL shares over possible Violations of Securities Laws by American Airlines Group Inc.
Investigation announced for Investors in NASDAQ: AAL shares over possible Violat …
An investigation was announced for investors of American Airlines Group Inc. (NASDAQ: AAL) shares over potential securities laws violations by American Airlines Group Inc. in connection with certain statements. Investors who purchased shares of American Airlines Group Inc. (NASDAQ: AAL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of
Deadline coming up on June 24th in Lawsuit for Investors who lost money with Compass Minerals International, Inc. (NYSE: CMP)
Deadline coming up on June 24th in Lawsuit for Investors who lost money with Com …
A deadline is coming up on June 24, 2024 in the lawsuit filed for certain investors of Compass Minerals International, Inc. (NYSE: CMP) over alleged securities laws violations by Compass Minerals International, Inc. Investors who purchased shares of Compass Minerals International, Inc. (NYSE: CMP) have certain options and there are strict and short deadlines running. Deadline: June 24, 2024. Compass Minerals International, Inc. (NYSE: CMP) stockholders should contact the Shareholders
Investigation announced for Investors who lost money with shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)
Investigation announced for Investors who lost money with shares of Regeneron Ph …
An investigation was announced for investors of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares over potential securities laws violations by Regeneron Pharmaceuticals, Inc. Investors who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)
Investigation announced for Investors in shares of BridgeBio Pharma, Inc. (NASDAQ: BBIO) over possible Violations of Securities Laws
Investigation announced for Investors in shares of BridgeBio Pharma, Inc. (NASDA …
An investigation was announced over potential securities laws violations by BridgeBio Pharma, Inc. in connection with certain financial statements. Investors who purchased shares of BridgeBio Pharma, Inc. (NASDAQ: BBIO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by BridgeBio Pharma, Inc. regarding its business, its prospects and its operations were

All 5 Releases


More Releases for Corporation

Endotherapy Devices Market Key Players: Hoya Corporation, Olympus Corporation, S …
A fresh report titled “Endotherapy Devices Market” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for Endotherapy Devices Market. The competition analysis is also a major part of the report. The global endotherapy devices market is projected to reach
Digital Living Room Market 2017-2025 | Samsung Corporation, Sharp Corporation, B …
Global Digital Living Room Market: Snapshot The living room gadgets in the early 1980s were predominantly televisions. Today, living rooms have evolved into a place with a number of devices thanks to inventions and evolution of the consumer electronics industry. Following this, researchers are focused on bridging the gaps between different devices in the living room by means of connected living rooms. This involves connecting the array of primary and secondary
Smart Camera Market || Key Players - Samsung Electronics Co., Canon Inc., Nikon …
Looking at the current market trends as well as the promising demand status of the Smart Camera Market, it can be projected that the future years will bring out positive outcomes. This research report added by MRRSE on its online portal delivers clear insight about the changing tendencies across the global Smart Camera Market. Readers can gather prime facets connected to the target market which includes product, end-use and application;
Global Healthcare Clinical Analytics Market to 2022| IBM Corporation, Cerner Cor …
Albany, NY, 3rd December : Recent research and the current scenario as well as future market potential of "Global Market Study on Healthcare Clinical Analytics: North America to be the Most Lucrative Market During the Assessment Period (2017 - 2022)" globally. Introduction Persistence Market Research delivers yet another unbiased, comprehensive and insightful report titled ‘Healthcare Clinical Analytics Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)’. Get PDF for more Professional and Technical insights
Endotherapy Devices Market Key Players : Hoya Corporation, Olympus Corporation, …
Endoscopy Devices Market is performed to examine abdominal pain, ulcers, digestive tract bleeding, and abnormal growths in the colon and other abdominal & gastrointestinal (GI) conditions. The minimally invasiveness of this procedure with fewer post operation complications makes it one of the most preferred and sought-after procedures in diagnostics and surgeries. The global endotherapy devices market is projected reach $5,015 million by 2024 from $3,369.0 million in 2017, growing at
Endoscopy Devices Market Share with Olympus Corporation, HOYA Corporation, Fujif …
Endoscopy Devices Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $40,854 million by 2022 from $27,273 million in 2015, registering a CAGR of 5.7% during the period 2016 to 2022. The flexible endoscopes are expected to dominate the global endoscopy devices market. North America is projected to continue its lead, accounting for more than one-third share of the global endoscopy devices market